A prospective randomized placebo-controlled trial presented evidence supporting antenatal N-acetylcysteine (NAC) supplementation to prevent imminent preterm birth in at-risk pregnancies. Conducted by Küster and colleagues and published in Pediatric Research, the study adds a new potential intervention point before delivery in women facing early labor risk. In pediatric infection care, reports also highlighted efforts to optimize vancomycin dosing in critically ill children with sepsis, addressing altered pharmacokinetics that can complicate effective and safe antimicrobial exposure. The clinical framing centers on improving outcomes through precision dosing strategies. Separately, multiple platform and drug-development updates in the same timeframe show the broader biotech focus on translating targeted interventions into measurable clinical endpoints across maternal-child health and high-acuity pediatric settings.